Tag: EGFR TKI

Browse exclusive Tags!

J INTS BIO Initiates Phase 1/2 Clinical Study of Novel EGFR TKI ‘JIN-A02’ for NSCLC Patients, South Korea

Learn about JIN-A02, a novel EGFR TKI for treating NSCLC patients. This Phase 1/2 study evaluates safety, pharmacokinetics, and anti-tumor activity.

Popular

Subscribe

spot_imgspot_img